Open Sinus Lift Technique With Simultaneous Implantation Using Platelet Rich Fibrin (PRF) Versus Nano-crystalline Hydroxyapatite
Atrophied Posterior Maxillary Ridge
About this trial
This is an interventional treatment trial for Atrophied Posterior Maxillary Ridge focused on measuring simultaneous implantation, Dental implant, Open sinus Lifting, PRF, platelet rich fibrin (PRF)
Eligibility Criteria
Inclusion Criteria:
- All patients should be seeking for implant supported prosthesis in posterior maxilla bilaterally
- All patients should have atrophied posterior maxillary ridge with the maximum height of the alveolar bone is from 3 mm to 5 mm
Exclusion Criteria:
- Ongoing steroid therapy;
- Uncontrolled diabetes;
- Recent cardiovascular diseases;
- Inflammation of the maxillary sinus;
- Previous radiant therapy for neoplastic pathologies
- Patient who have had previous failed sinus augmentation, or exhibited pathological finding or had a history of maxillary sinus disease or operations or whose medical condition might increase surgical risk of the research protocol were excluded.
Sites / Locations
- Faculty of oral and dental medicineRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
Control group ( Hydroxyappetite)
Test group (PRF)
Patients will undergo open sinus lift using nano crystalline hydroxyapatite as augmentation material and placing implants simultaneously then evaluation of bone quantity in open sinus lift technique with simultaneous implantation ( Nano crystalline hydroxyapatite)
Patients will undergo open sinus lift using PRF as sole augmentation material and placing implants simultaneously then Evaluation of bone quantity in open sinus lift technique with simultaneous implantation (PRF)